Raymond B. Wynn

Radiation Oncology

2501 Kentucky Ave
Paducah, KY 42003

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 17, 2019

Correlation between real-time intraoperative and postoperative dosimetry and its implications on intraoperative planning.

Correlation between real-time intraoperative and postoperative dosimetry and its implications on intraoperative planning.

Journal: Brachytherapy

Published: August 21, 2018

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 31, 2016

Clinical implementation and evaluation of the Acuros dose calculation algorithm.

Clinical implementation and evaluation of the Acuros dose calculation algorithm.

Journal: Journal of applied clinical medical physics

Published: November 18, 2016

Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.

Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.

Journal: JAMA oncology

Published: November 26, 2015

Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617.

Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617.

Journal: Journal of the National Cancer Institute

Published: June 09, 2015

Counterpoint: Diversity and Inclusion: Works in Progress.

Counterpoint: Diversity and Inclusion: Works in Progress.

Journal: Journal of the American College of Radiology : JACR

Published: May 04, 2015

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.

Journal: The Lancet. Oncology

Published: January 21, 2015

Improving diversity, inclusion, and representation in radiology and radiation oncology part 1: why these matter.

Improving diversity, inclusion, and representation in radiology and radiation oncology part 1: why these matter.

Journal: Journal of the American College of Radiology : JACR

Published: February 07, 2014

Improving diversity, inclusion, and representation in radiology and radiation oncology part 2: challenges and recommendations.

Improving diversity, inclusion, and representation in radiology and radiation oncology part 2: challenges and recommendations.

Journal: Journal of the American College of Radiology : JACR

Published: February 06, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026